SEARCH

SEARCH BY CITATION

References

  • 1
    Andersen, J.C. (1994) Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. New England Journal of Medicine, 330, 15601564.DOI: 10.1056/NEJM199406023302203
  • 2
    Andrew, M., Blanchette, V., Adams, M., Ali, K., Barnard, D., Chan, K.W., De Veber, L.B., Esseltine, D., Israels, S., Korbrinsky, N., Luke, B., Milner, R.A., Woloski, M.R. & Vegh, P. (1992) A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. Journal of Pediatrics, 120, 522527.
  • 3
    Blanchette, V., Freedman, J. & Garvey, B. (1998) Management of chronic immune thrombocytopenic purpura in children and adults. Seminars in Hematology, 35, (Suppl. 1), 3651.
  • 4
    Blanchette, V., Imbach, P., Andrew, M., Adams, M., McMillan, J., Wang, E., Milner, R., Ali, K., Barnard, D., Bernstein, M., Chan, K.W., Esseltine, D., De Veber, B., Israels, S., Kobrinsky, N. & Luke, B. (1994) Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet, 344, 703707.
  • 5
    Blanchette, V.S., Luke, B., Andrew, M., Sommerville-Nielsen, S., Barnard, D., De Veber, B. & Gent, M. (1993) A prospective, randomized trial of high dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. Journal of Pediatrics, 123, 989995.
  • 6
    Bolton-Maggs, P. & Moon, I. (1997) Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet, 350, 620623.
  • 7
    Borgna-Pignatti, C., Rugolotto, S., Nobili, B., Amendola, G., De Stefano, P., Maccario, R. & Locatelli, F. (1997) A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood. Journal of Pediatrics, 130, 1316.
  • 8
    Buchanan, G. & Holtkamp, C. (1984) Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura: a randomised clinical trial. American Journal of Pediatric Hematology/Oncology, 6, 355361.
  • 9
    Davis, H.P. & Raffles, A. (1997) Childhood idiopathic thrombocytopenic purpura. (Letter). Lancet, 350, 1252.
  • 10
    Dowell, S.F. & Bresee, J.S. (1993) Severe varicella associated with steroid use. Pediatrics, 92, 223228.
  • 11
    Eden, O.B. & Lilleyman, J.S. (1992) Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Archives of Diseases in Childhood, 67, 10561058.
  • 12
    George, J.N., Woolf, S.H., Raskob, G.E., Wasser, J.S., Aledort, L.M., Ballem, P.J., Blanchette, V.S., Bussel, J.B., Cines, D.B., Kelton, J.G., Lichtin, A.E., McMillan, R., Okerbloom, J.A., Regan, D.H. & Warrier, I. (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood, 88, 340.
  • 13
    Holdsworth, R.J., Irving, A.D. & Cuschieri, A. (1991) Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. British Journal of Surgery, 78, 10311038.
  • 14
    Imbach, P., Berchtold, W., Hirt, A., Mueller-Eckhardt, C., Rossi, E., Wagner, H.P., Gaedicke, G., Joller, P., Muller, B. & Barandun, S. (1985) Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet, ii, 464468.DOI: 10.1016/S0140-6736(85)90400-3
  • 15
    Law, C., Marcaccio, M., Tam, P., Heddle, N. & Kelton, J.G. (1997) High dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. New England Journal of Medicine, 336, 14941498.DOI: 10.1056/NEJM199705223362104
  • 16
    Lilleyman, J.S. (1983) Management of childhood idiopathic thrombocytopenic purpura. British Journal of Haematology, 54, 1114.
  • 17
    Lilleyman, J.S. (1994) Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Archives of Diseases in Childhood, 71, 251253.
  • 18
    Medeiros, D. & Buchanan, G.R. (1996) Current controversies in the management of idiopathic thrombocytopenic purpura during childhood. Pediatric Clinics of North America, 43, 757772.
  • 19
    Najean, Y., Rain, J.D. & Billotey, C. (1997). The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. British Journal of Haematology, 97, 547550.DOI: 10.1046/j.1365-2141.1997.832723.x
  • 20
    Rosthoj, S., Nielsen, S. & Pedersen, F.K. (1996) Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Acta Paediatrica, 85, 910915.
  • 21
    Saxon, B.R., Blanchette, V.S., Butchart, S., Lim-Yin, J. & Poon, A.O. (1998) Reticulated platelet counts in the diagnosis of acute immune thrombocytopenic purpura. Journal of Pediatric Hematology and Oncology, 20, 4448.DOI: 10.1097/00043426-199801000-00007
  • 22
    Singer, D.B. (1973) Postsplenectomy sepsis. Perspectives in Pediatric Pathology, 1, 285311.
  • 23
    Vermeulen, M. (1994) Treatment of childhood immune thrombocytopenic purpura. (Letter). Lancet, 344, 11551156.DOI: 10.1016/S0140-6736(94)90661-0
  • 24
    Warrier, I., Bussel, J.B., Valdez, L., Barbosa, J. & Beardsley, D.S. (1997) Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group. Journal of Pediatric Hematology and Oncology, 19, 197201.DOI: 10.1097/00043426-199705000-00004
  • 25
    Yap, P.L. (1996) Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data. Clinical Therapeutics, 18, (Suppl. B), 4358.DOI: 10.1016/S0149-2918(96)80195-0